About Mundipharma
Mundipharma is a Healthcare company based in London (United Kingdom) founded in 1993. Therapeutics for oncology, rheumatoid arthritis, and respiratory conditions are developed. The company has 95 employees. Mundipharma has completed 3 acquisitions, including Cinfa Biotech, Continental Industry and Tolmar. Its website mundipharma.com draws about 26 thousand monthly visits. Mundipharma offers products and services including Medicines. Its focus areas include Life Sciences, Oncology, Drugs and Diversified. Its legal entity is Mundipharma A/S.
Company details
Therapeutics targeting oncology, rheumatoid arthritis, and respiratory disorders are developed by the company, which was founded in 1993 and is headquartered in London, United Kingdom. Products including infliximab for rheumatoid arthritis treatment, formoterol for asthma management, bendamustine hydrochloride for hematological malignancies, and buprenorphine for pain relief are provided. Product availability is determined by regulatory registrations and varies across countries where operations are conducted.
- Headquarters London, United Kingdom
- Employees 95
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website mundipharma.com
- Social LinkedIn
- Legal Name Mundipharma A/S
- Annual Revenue$31.91 M (USD)17as on Dec 31, 2020
- Net Profit$2.28 M (USD)104as on Dec 31, 2020
- Employee Count95
- Investments & AcquisitionsCinfa Biotech
& 2 more
Products & Services of Mundipharma
Mundipharma offers a comprehensive portfolio of products and services, including Medicines.
Products for therapeutic areas and patient treatment worldwide.
People of Mundipharma
249 people are tracked at Mundipharma (104 in leadership, 145 in team); the tracked headcount is 95.
| Name | Role | Group |
|---|---|---|
Francois Bernard | General Manager, France, Switzerland, Austria and CEE | Leadership |
Ravindra Deore | Senior Medical Director, Global Medical Affairs At Mundipharma | Leadership |
Masahiko Yanagita | Country Head Of Medical Affairs | Leadership |
Anna Kjellberg | European Director of People and Business Transformation | Leadership |
Alexa Hooper | Chief Privacy Officer & IT Counsel | Leadership |
Basel Houdali Mpharm | Head Of Regulatory Strategy | Leadership |
Amiel Barrimond | Senior Director, Total Reward, People Analytics & Payroll | Leadership |
Eduardo Aguiar | Medical Director, Global Medical Operations | Leadership |
Courtney Wild Assoc. Cipd | HR Partner | Leadership |
Shady Kandil | Head Of Medical Middle East , Turkey And Africa | Leadership |
Tam Cilgi | Senior Director, Global Regulatory Strategy And Labelling Lead | Leadership |
Marc Princen | Global CEO | Leadership |
Sarah B. | Vice President Of Quality | Leadership |
Maria Francis | Director Change Management | Leadership |
Bhavik Pancholi | Learning, Development & Inclusion Director | Leadership |
Gemma Whatley | Director Of Compliance Monitoring And Transparency | Leadership |
Katherine Guzman | Executive Director, Global Business Development And Alliance Management | Leadership |
James Swift | Senior Vice President Compliance And Internal Audit | Leadership |
Petra Molan | Chief Commercial Officer | Leadership |
Yuri Martina | Chief Development & Medical Officer | Leadership |
229 more people are available in the full profile.
Complete people profiles for Mundipharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mundipharma
Mundipharma has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Cinfa Biotech, Continental Industry and Tolmar.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Biosimilars for oncology and inflammatory diseases are developed in Spain. | cinfabiotech.com | Navarres, Spain | 2013 | Oct 2018 | •••• | |
Specialty pharmaceutical products are developed, manufactured, and commercialized by Tolmar. | tolmar.com | Fort Collins, United States | 2007 | Feb 2018 | •••• | |
Training services for cement manufacturing and grinding systems are provided. | phoenix-ag.com | Hamburg, Germany | 1856 | Jun 2014 | •••• |
Complete acquisition details for Mundipharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Mundipharma
4 dated milestones of Mundipharma across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Mundipharma is founded.
- Acquisition Acquires Continental Industry.
- Acquisition Acquires Tolmar.
- Acquisition Acquires Cinfa Biotech.
Web traffic of Mundipharma
The website of Mundipharma (mundipharma.com) receives about 26.5K visits a month and ranks #1,152,343 among all websites worldwide, #1,438 in Biotechnology and Pharmaceuticals.
- Monthly visits26.5K
▲ 9.4% vs previous month
- Unique visitors10.9K
per month
- Global rank#1,152,343
among all websites
- Category rank#1,438
Health · Biotechnology and Pharmaceuticals
- Bounce rate49%
- Pages per visit1.8
- Average visit28 sec
- DevicesDesktop 25% · Mobile 75%
Websites whose visitors overlap most with Mundipharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
napp.co.uk | napp.co.uk | 100% | #6,458,178 | – | |
| biocentury.com | 92% | 85.7K | #514,907 | View details | |
| hennig-am.de | 87% | 14.6K | #2,248,528 | View details | |
| umeshmodigroup.com | 85% | 5.3K | #2,442,534 | View details | |
pharmajobs.com | pharmajobs.com | 85% | #2,068,909 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 30 similar websites and full traffic analytics for Mundipharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 30 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mundipharma
Complete news archive for Mundipharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mundipharma
Mundipharma was founded in 1993.
Mundipharma is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Mundipharma has 95 employees.
Annual revenue of Mundipharma is $31.91M as on Dec 31, 2020.
Therapeutics targeting oncology, rheumatoid arthritis, and respiratory disorders are developed by the company, which was founded in 1993 and is headquartered in London, United Kingdom. Products including infliximab for rheumatoid arthritis treatment, formoterol for asthma management, bendamustine hydrochloride for hematological malignancies, and buprenorphine for pain relief are provided. Product availability is determined by regulatory registrations and varies across countries where operations are conducted.
Mundipharma offers Medicines.
Mundipharma has made 3 acquisitions, including Cinfa Biotech, Continental Industry, and Tolmar.
Mundipharma operates through Mundipharma A/S.